Nomura Raises REMEGEN TP to HKD89.44, Maintains Neutral RatingAASTOCKS News·2 days ago, 02:37 AM09995-2.36%688331-1.10%
RemeGen Plunges 10% as Hong Kong Biotech Sector SlidesHK Stock Market Update·Jul 17 at 12:20 AM09995-2.36%
RemeGen falls 8% in Hong Kong trade on sector weaknessHK Stock Market Update·Jul 16 at 09:30 PM09995-2.36%
Hong Kong Healthcare and Industrials: RemeGen Advances as L.K. Tech Pivots to AI InfrastructureGlobal Report·Jul 9 at 09:02 PM09995-2.36%01187-1.51%
RemeGen climbs 4% in Hong Kong trading on no catalystHK Stock Market Update·Jul 9 at 09:00 PM09995-2.36%
RemeGen rises sharply in intraday trade to HKD83.20HK Stock Market Update·Jul 9 at 12:10 AM09995-2.36%
Hong Kong Market Flows: CNOOC's Record Output and Dynasty Digital's PivotGlobal Report·Jul 8 at 10:32 PM09995-2.36%01988+1.12%
RemeGen rises over 8% on drug insurance approval optimismHK Stock Market Update·Jul 3 at 01:30 AM09995-2.36%
RemeGen Deploys Idle Funds Into SPDB Wealth Products in Discloseable TransactionTip Ranks·Jul 2 at 07:38 AM688331-1.10%09995-2.36%
RemeGen jumps more than 8% on improved innovation drug payment frameworkHK Stock Market Update·Jul 2 at 01:00 AM09995-2.36%
Hong Kong Stock Movement: Medical Insurance Directory Preliminary Review Approved, REMEGEN Rises 16.65%HK Stock Alerts·Jun 29 at 01:37 AM09995-2.36%
Hong Kong Stock Movement: REMEGEN rises 15.43%, favorable initial review of medical insurance catalog boosts innovative drug sectorHK Stock Alerts·Jun 28 at 10:32 PM09995-2.36%
Hong Kong Stock Movement: REMEGEN rises 14.14%, concerns arise over Huafeng Technology's lifting of restrictions on share reductionHK Stock Alerts·Jun 28 at 09:27 PM09995-2.36%